Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

medRxiv logoLink to medRxiv
[Preprint]. 2025 Oct 22:2025.10.20.25338173. [Version 1] doi: 10.1101/2025.10.20.25338173

The ENGAGE Study: A Randomized Trial Optimizing Uptake of Germline Cancer Genetic Services in Childhood Cancer Survivors

Tara O Henderson, Brian Egleston, Sarah Howe, Mary Ashley Allen, Rajia Mim, Linda G Fleisher, Elena B Elkin, Kevin C Oeffinger, Kevin R Krull, Demetrios Ofidis, Briana Mcleod, Hannah Griffin, Elisabeth M Wood, Cara N Cacioppo, Sarah Brown, Melody Perpich, Gregory T Armstrong, Angela R Bradbury
PMCID: PMC12633570  PMID: 41282828

Summary

Background

Identifying childhood cancer survivors who are already at high risk of subsequent neoplasms and may also have an inherited genetic susceptibility is essential for effective surveillance and prevention. This trial evaluated the effectiveness of remote, centralized telehealth genetic services in increasing service uptake.

Methods

Childhood Cancer Survivor Study (CCSS) participants at the St. Jude Research Hospital, who were > 18 years old and survivors of a CNS tumor, sarcoma, or more than one primary cancer, were recruited for the study. After completing a baseline survey, participants were randomly assigned to one of three arms: remote telehealth genetic services via phone, videoconference, or usual care. Uptake of genetic services was obtained through study records and the six-month Status Survey.

Findings

Of the 391 participants recruited, 262 were assigned to remote telehealth services (via phone or videoconference) and 129 to usual care. At six months, 43% (113/262) of participants in remote telehealth services received genetic services compared to 15% (19/129) in the usual care group (OR = 4·4, 95% CI 2·5-8·0, p<0·0001). Uptake of genetic counseling (42% vs. 15%, p < 0·0001) and genetic testing (19% vs. 9%, p = 0·020) were higher in remote telehealth services. Factors associated with higher uptake included not having high-deductible health insurance (OR = 1·67, 95%CI 1·00-2·91, p = 0·049) and lower perceived cost of testing (OR = 1·51, 95%CI 1·17-1·96, p = 0·0014). Top barriers included experiencing higher levels of depression (OR=0·91, 95%CI 0·85-0·98, p = 0·0067) and anxiety (OR=0·93, 95%CI 0·87-1·00, p = 0·036).

Interpretation

Remote telehealth genetic services improve genetic counseling and testing uptake in childhood cancer. Addressing remaining barriers could maximize their impact and ensure equitable access for childhood cancer survivors and their families.

Funding

National Cancer Institute (R01-CA237369, U24-CA55727).

Clinical Trial Registration

NCT 04455698 at http://www.ClinicalTrials.gov

Full Text Availability

The license terms selected by the author(s) for this preprint version do not permit archiving in PMC. The full text is available from the preprint server.


Articles from medRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES